Incannex Healthcare gains ethics green light for Phase 2 cli

Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) is preparing to advance its clinical trial assessing the treatment of rheumatoid arthritis to the second...

Related Keywords

New Zealand , Camberwell , Victoria , Australia , Australian , Mark Bleackley , Nasdaq , Incannex Healthcare Ltd , Human Research Ethics Committees , Emeritus Research , Avance Clinical ,